Nighttime cycling of Enterra pacemaker for gastroparesis
Part of Digestive system clinical trials.
This study tests a new way to program the Enterra stomach pacemaker so it cycles at night, aiming to improve gastroparesis symptoms. It's for people who already have the device and have stable symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 70 years old.
- You already have an Enterra stomach pacemaker (the device must have been placed within the last 4 years).
- Your gastroparesis symptoms should be stable and you are on a steady treatment plan.
- You need to be able to read and understand English, and have a device with internet access at home.
- You cannot have nausea or vomiting that is severe at night or in the morning, and you must have a regular sleep schedule.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how a special implanted device that sends gentle electrical pulses to your stomach can help reduce chronic belly pain caused by gastroparesis (a condition where the stomach doesn't empty food properly). You must already have this device implanted and be experiencing moderate to severe daily pain.
This study records outcomes for people who need a new implanted stomach electrical stimulation device for severe stomach emptying problems (gastroparesis) that haven’t improved with usual treatments. It may help doctors learn which patients benefit most and how to manage the device over time.
This study follows people with drug-refractory gastroparesis (stomach paralysis symptoms that don’t improve with usual medicines) to better understand how symptoms and nutrition change over time. Your information may help researchers understand patterns that could improve care.
This study tests a non-invasive treatment called percutaneous electrical nerve field stimulation to see if it can help control symptoms like nausea and vomiting in people with diabetes-related gastroparesis. It aims to ease digestive symptoms and calm overactive nerves.
This study looks at how a surgically implanted device that stimulates the stomach (called a GES device) affects your body's insulin levels. Researchers will collect blood samples over several hours to understand if and how the device influences insulin production.
This trial tests a new way to program an implanted device (Enterra®) to better treat severe nausea and vomiting caused by gastroparesis. If you have frequent nausea and vomiting despite other treatments, this study might help find a better setting for your device.
Hear when a new Gastroparesis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.